---
$id: https://graph.org.ai/products/commodity/51172320
$type: Product
source: UNSPSC
code: "51172320"
title: "Deferasirox"
class: "51172300"
classTitle: "Antidotes and emetics"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Deferasirox

**UNSPSC Code**: 51172320
**Class**: [Antidotes and emetics](Antidotes and emetics.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a metal chelator with the molecular formula C21H15N3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V8G4MOF2V9, chemically known as 4-(3,5-bis-(hydroxy-phenyl)-1,2,4)triazol-1-yl)-benzoic acid but generally known as deferasirox, which bears US NIH Compound Identifier 5493381. European Medicines Agency schedules Deferasirox in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB21981. The term DEFERASIROX is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3, 2002, List 48). World Health Organization schedules deferasirox in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule deferasirox under HS 29339990 and SITC 51577. As of Q4 2014, DEFERASIROX remains the US FDA Preferred Term for this commodity. Deferasirox bears US NLM identifiers UMLS ID C1619629 and NCI Concept Code C48384. SMILES: O=C1/C(=C2/N([NH]/C(=C3\C(=O)C=CC=C3)[NH]2)C2CCC(CC2)C(=O)O)C=CC=C1.

